Delivery Order SPE2DB24D2216-SPE2DB25FGNZA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta (tapentadol) 100 mg tablets in a quantity of 100 units under a firm fixed-price contract. The order, issued on October 22, 2025, carries a ceiling value of $4,550.07 with an ultimate completion date of October 23, 2025. This non-competitive delivery order represents a routine pharmaceutical procurement supporting military and federal healthcare needs. The place of performance is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,253.88 to AmerisourceBergen Drug Corp for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100 units. This competitive delivery order, which was not set-aside for any socioeconomic category, was awarded on July 14, 2025, with an ultimate completion date of July 15, 2025, under firm fixed-price terms. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $1,929.40 firm fixed price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Nucynta (tapentadol) 50 mg, with an ultimate completion date of June 17, 2025. This non-set-aside competitive award leverages AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.999 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical...
- The Defense Logistics Agency awarded a $1,522.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100. This is a non-set-aside contract with a completion date of September 26, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving critical federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $3,457.97 to AmerisourceBergen Drug Corp for the supply of Nucynta (tapentadol) 100 mg tablets in quantities of 100 units. This firm fixed-price, competitively awarded delivery order was executed on October 22, 2025, with an ultimate completion date of October 23, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical procurement. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta (tapentadol) 50 mg tablets in a quantity of 100 units. This firm fixed-price delivery order, issued on June 16, 2025, carries a ceiling value of $2,450.08 and is scheduled for completion by June 17, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a non-competitive, non-set-aside delivery order and is...
- The Defense Logistics Agency awarded a $1,837.56 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with a completion deadline of July 30, 2025, and represents a child contract under AmerisourceBergen's larger federal contract portfolio. The award carries no set-aside designation, indicating it was competitively awarded. Performance will occur at the vendor's...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Nucynta ER (tapentadol extended-release) 100mg tablets, valued at $6,005.43. This firm fixed-price delivery order, which represents a child contract under a larger vehicle, is scheduled for completion by August 5, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award was made through open...
- The Defense Logistics Agency awarded a $2,862.27 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Nucynta (tapentadol) 100 mg tablets in a 100-count package. This competitively awarded, non-set-aside contract will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025. The delivery order represents a child contract action under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100 units. This firm fixed price delivery order, valued at $2,384.48, was competitively awarded without set-aside restrictions and is scheduled for completion by September 11, 2025. The award represents a child contract under AmerisourceBergen's larger...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB25FGNZADelivery Order
The Defense Logistics Agency awarded a $2,450.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Nucynta (tapentadol) 50 mg, with a completion date of June 16, 2025. This non-set-aside competitive award was issued to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, the company's headquarters. The delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply framework with the federal government. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medications and medical commodities to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen maintains an extensive portfolio of federal contracts delivering brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 6/13/25 |